These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 434811)

  • 21. Cytofluorometric identification of plasmin-sensitive factor XIIIa binding to platelets.
    Kreager JA; Devine DV; Greenberg CS
    Thromb Haemost; 1988 Aug; 60(1):88-93. PubMed ID: 2903577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibrin-stabilizing factor (factor XIII) in the fetus and the newborn infant.
    Henriksson P; Hedner U; Nilsson IM; Boehm J; Robertson B; Lorand L
    Pediatr Res; 1974 Sep; 8(9):789-91. PubMed ID: 4413463
    [No Abstract]   [Full Text] [Related]  

  • 23. Calcium-induced dissociation of human plasma factor XIII and the appearance of catalytic activity.
    Cooke RD
    Biochem J; 1974 Sep; 141(3):683-91. PubMed ID: 4463958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibrin-stabilizing factor inhibitors. 4. Action of some synthetic fibrinoligase inhibitors on human platelet aggregation.
    Lundén R; Hartkoorn A; Nilsson JL; Stenberg P; Bruner-Lorand J; Lorand L
    J Med Chem; 1972 Jan; 15(1):98-9. PubMed ID: 5007105
    [No Abstract]   [Full Text] [Related]  

  • 25. Packaging zinc, fibrinogen, and factor XIII in platelet alpha-granules.
    Marx G; Korner G; Mou X; Gorodetsky R
    J Cell Physiol; 1993 Sep; 156(3):437-42. PubMed ID: 8360253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gly-Pro-Arg-Pro modifies the glutamine residues in the alpha- and gamma-chains of fibrinogen: inhibition of transglutaminase cross-linking.
    Achyuthan KE; Dobson JV; Greenberg CS
    Biochim Biophys Acta; 1986 Aug; 872(3):261-8. PubMed ID: 2873839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of platelet factor XIIIa-catalyzed reactions by calmodulin.
    Cohen I; Kahn DR; Drisdel RC
    Biochim Biophys Acta; 1986 Sep; 883(2):265-70. PubMed ID: 2874832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new assay method for factor XIII using a fluorescence polarization analyzer, based on change in the rotary brownian motion.
    Yamada K; Meguro T
    Thromb Res; 1977 Nov; 11(5):557-66. PubMed ID: 563114
    [No Abstract]   [Full Text] [Related]  

  • 29. Regulation of thrombin cleavage of plasma factor XIII bound to fibrin.
    Greenberg CS; Achyuthan KE; Miraglia CC; Dobson JV
    Ann N Y Acad Sci; 1986; 485():140-3. PubMed ID: 3471145
    [No Abstract]   [Full Text] [Related]  

  • 30. Vitronectin is a substrate for transglutaminases.
    Sane DC; Moser TL; Pippen AM; Parker CJ; Achyuthan KE; Greenberg CS
    Biochem Biophys Res Commun; 1988 Nov; 157(1):115-20. PubMed ID: 2461707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measurement of interprotein distances in the acto-subfragment 1 rigor complex.
    Takashi R; Kasprzak AA
    Biochemistry; 1987 Nov; 26(23):7471-7. PubMed ID: 3427088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of kinetic properties of the ATPase reaction of arterial smooth muscle myosin with skeletal muscle myosin.
    Takeuchi K
    J Biochem; 1980 Dec; 88(6):1693-702. PubMed ID: 6450756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Muscular myosin structural and functional changes during interaction with ATP and bivalent ions].
    Bogach PG; Zima VL; Danilova VM; Minchenko PG; Kulikova NV
    Ukr Biokhim Zh (1978); 1981; 53(5):9-12. PubMed ID: 7292626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors affecting factor XIII assay by dansyl cadaverine incorporation.
    Sheltawy MJ; Miloszewski K; Losowsky MS
    Thromb Diath Haemorrh; 1972 Dec; 28(3):483-8. PubMed ID: 4675269
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluation of the fibrin stabilizing factor in human platelets: its content in normal thrombocytes and in platelets with functional defects.
    Wenzel E; Oppolzer R
    Acta Univ Carol Med Monogr; 1972; 53():173-8. PubMed ID: 4133928
    [No Abstract]   [Full Text] [Related]  

  • 36. Tb(III)-ion-binding-induced conformational changes in platelet factor XIII.
    Achyuthan KE; Mary A; Greenberg CS
    Biochem J; 1989 Jan; 257(2):331-8. PubMed ID: 2564774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retention of platelet fibrin stabilizing factor during the platelet release reaction and clot retraction.
    Joist JH; Niewiarowski S
    Thromb Diath Haemorrh; 1973 Jun; 29(3):679-83. PubMed ID: 4271547
    [No Abstract]   [Full Text] [Related]  

  • 38. Platelet factor XIII becomes active without the release of activation peptide during platelet activation.
    Muszbek L; Polgár J; Boda Z
    Thromb Haemost; 1993 Mar; 69(3):282-5. PubMed ID: 8097064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calcium and thiol reactivity of human plasma clotting factor XIII.
    Cooke RD; Pestell TC; Holbrook JJ
    Biochem J; 1974 Sep; 141(3):675-82. PubMed ID: 4463957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transglutaminase-catalyzed insertion of a fluorescent probe into the protease-sensitive region of rhodopsin.
    Pober JS; Iwanij V; Reich E; Stryer L
    Biochemistry; 1978 May; 17(11):2163-8. PubMed ID: 27209
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.